" said Dr. Kara Fedders, O.D., the practice's resident dry eye specialist. "The ZEST treatment is a breakthrough that addresses both the symptoms and the causes of dry eye, which are often overlooked. I'm thrilled to bring this effective new option to our...
Yuyu Pharmaceutical CEO Robert Yu (second from left) presented the poster study for YP-P10, its new dry eye syndrome treatment, at the 2022 ARVO conference, held in Denver, Col., from Sunday to Wednesday. ARVO, established in 1928, is the world's largest ophthalmology society and has 12,...
New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. Br J Ophthalmol. 1999; 83 :767–70.Tsubota, K.; Monden, Y.; Yagi, Y.; Goto, E.; Shimmura, S.; New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery. British ...
In June 2024, a canalicular gel device (Lacrifill, Nordic Pharma) was introduced to the US market, and a recent study has shown it to be a safe, well-tolerated, and effective treatment for dry eye.1 This device offers a new option for managing a condition that affects millions of patie...
Cequa was assessed in a phase 3 confirmatory study involving 744 patients with dry eye who were treated with Cequa or its vehicle. After 12 weeks of treatment, Cequa led to a statistically significant improvement in the primary endpoint, Schirmer's score (a measurement of tear production;P< ....
1.First, your eye doctor will use the LipiScan imagingdevice to examine your Meibomian glands. This will help your doctor make a diagnosis, which may involve additional testing. 2.If it’s determined that you do have MGD, you can proceed with receiving the 12-minute LipiFlowtreatment.Befor...
Treatment Options for Correcting Refractive Errors Now you may be wondering if there is a solution to it. The fact is, there are some ways you can manage it or even correct the refractive errors. As you might know, eyeglasses are the most common choice. They come in various styles and ...
Impact of anti-VEGF treatment and patient characteristics on vision outcomes in neovascular age-related macular degeneration: up to 6-year analysis of the AAO IRIS Registry. Ophthalmol Sci. 2023;4(2):100421. doi:10.1016/j.xops.2023.100421 5. Adrean SD, Chaili S, Grant S,...
New Jersey. The Glaukos iStent infinite® Trabecular Micro-Bypass System is an implant of 3 microstents which reduce the intraocular pressure (IOP) of the eye. It is indicated for use in adult patients with primary open-angle glaucoma in whom previous medical and surgical treatment has failed...
The scoop: Joining a crowded dry eye disease market, Bausch + Lomb and Novaliq’s Miebo is the first treatment to directly target tear evaporation, targeting what Bausch + Lomb CEO Brent Saunders has called a “significant unmet need.” Dry eye disease impacts millions of people ...